250 mg - Nelfinavir;
Without a Prescription
Nelfinavir in combination with other antiretroviral agents is prescribed for the treatment of HIV infection.
Nelfinavir can be used in patients with mild hepatic impairment without any dose adjustment. Nelfinavir should not
be used in patients with either moderate or severe hepatic impairment.
Pediatrics Patients (2-13 years):
In children 2 years of age and older, the recommended oral dose of Nelfinavir 250 mg tablet is
45 to 55 mg/kg twice daily or 25 to 30 mg/kg three times daily. All doses should be taken with a meal. Doses higher than
the adult maximum dose of 2500 mg per day have not been studied in children.
Nelfinavir recommended dose is 1250 mg (five 250 mg tablets) twice daily or 750 mg (three 250 mg tablets) three times daily.
Nelfinavir should be taken with a meal. Patients unable to swallow the 250 or 625 mg tablets may dissolve the tablets in a
small amount of water. Once dissolved, patients should mix the cloudy liquid well, and consume it immediately. The
glass should be rinsed with water and the rinse swallowed to ensure the entire dose is consumed.
Nelfinavir is contraindicated in patients with clinically significant hypersensitivity to any of its components.
Co-administration of nelfinavir is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events. These drugs are listed in Table 7.
Container of 100 tablets.